News
![Is BioNTech Stock a Buy Now?: https://g.foolcdn.com/editorial/images/751618/doctor-vaccinating-a-patient.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXE3YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ba5c4ca69c6da575a698ec1f8cfbd5f8755c47b5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/doctor-vaccinating-a-patient.jpg?locale=us)
Is BioNTech Stock a Buy Now?
BioNTech (NASDAQ: BNTX) is the lesser-known member of the pair -- which also includes Pfizer -- that developed and marketed Comirnaty, one of the leading coronavirus vaccines on the market. However
![Better Stock Buy: AT&T vs. C3.ai: https://g.foolcdn.com/editorial/images/752007/young-trader-at-home.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM0s3YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--daacf00c0fb05c27dfdb6deeabc47e53a2335ff7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/young-trader-at-home.jpg?locale=us)
Better Stock Buy: AT&T vs. C3.ai
AT&T (NYSE: T) and C3.ai (NYSE: AI) generally appeal to different types of tech investors. AT&T, one of the largest telecom companies in America, is usually owned for stability and dividends instead
![3 Dental Supply Stocks You Can Sink Your Teeth Into: https://g.foolcdn.com/editorial/images/751961/sitting-at-dental-chair-dentist-patient.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2k3YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--39ba578eb99a949bb8ef57023c5fe030c8b8e8d2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/sitting-at-dental-chair-dentist-patient.jpg?locale=us)
3 Dental Supply Stocks You Can Sink Your Teeth Into
Like regular flossing, dental supply companies are sometimes overlooked, but Henry Schein (NASDAQ: HSIC), Dentsply Sirona (NASDAQ: XRAY), and Patterson Companies (NASDAQ: PDCO) are all thriving
EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
![Novartis Ag (NVS) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeSt3V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9dfca4603c1fc3af5c96a68f8938e1fa8ce6aed8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/featured-transcript-logo-template-2023-01-12.jpg?locale=us)
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Novartis Ag (NYSE: NVS)Q3 2023 Earnings CallOct 24, 2023, 8:00 a.m. ET
Operator
Source Fool.com
![Why LianBio Stock Is Skyrocketing Today: https://g.foolcdn.com/editorial/images/752037/scientists-asian.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK2E2YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5d595f0b19c40d8839b7eb6d45015f72a5148822/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/scientists-asian.jpg?locale=us)
Why LianBio Stock Is Skyrocketing Today
Shares of LianBio (NASDAQ: LIAN) were skyrocketing 132.4% higher as of 11:11 a.m. ET on Tuesday. The huge gain came after the company announced that it entered into an agreement to hand over
![Centene (CNC) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeSt3V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9dfca4603c1fc3af5c96a68f8938e1fa8ce6aed8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/featured-transcript-logo-template-2023-01-12.jpg?locale=us)
Centene (CNC) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Centene (NYSE: CNC)Q3 2023 Earnings CallOct 24, 2023, 8:30 a.m. ET
Operator
Source Fool.com
![Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.: https://g.foolcdn.com/editorial/images/751839/a-doctor-looking-at-a-tablet-with-another-person.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN2E2YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--770f4806bd7760bcd3363ff074693139a17d6996/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-doctor-looking-at-a-tablet-with-another-person.jpg?locale=us)
Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.
Abbott Laboratories (NYSE: ABT) has been a disappointing investment in recent years. While COVID-19 testing gave the business a boost, this has largely been a slow-growing company. And since 2020
![2 Beaten-Down Stocks That Haven't Been This Cheap in Over 6 Years: https://g.foolcdn.com/editorial/images/751834/a-couple-of-investors-looking-at-a-series-of-charts.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd2k2YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6a410c9ea50f915a21135084e1ea91b60b921822/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-couple-of-investors-looking-at-a-series-of-charts.jpg?locale=us)
2 Beaten-Down Stocks That Haven't Been This Cheap in Over 6 Years
Many growth stocks have come under pressure this year due to worsening macroeconomic conditions. Investors are concerned about inflation and a slowdown in the economy. Two stocks that have been
![The Best Stocks to Invest $5,000 In Right Now: https://g.foolcdn.com/editorial/images/751878/gettyimages-103919680.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOGk1YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--809864edb1811da2fb7742c25c49a4580ec67314/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/gettyimages-103919680.jpg?locale=us)
The Best Stocks to Invest $5,000 In Right Now
Bear markets and bull markets come and go, so it's best to avoid building your portfolio around one specific market phase. Instead, pick up shares of companies with potential to grow your wealth
![2 High-Yield Dividend Stocks to Buy Now and Hold for a Decade or Longer: https://g.foolcdn.com/editorial/images/751708/stock-market-trader-at-home-getty.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBODI1YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--31389748b29c194771215cebc2cbcdee503e017c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/stock-market-trader-at-home-getty.jpg?locale=us)
2 High-Yield Dividend Stocks to Buy Now and Hold for a Decade or Longer
These days, finding dividend payers that offer eye-popping yields is as easy as clicking the sort button on your favorite stock screener. Unfortunately, the vast majority of stocks that float to the
![Why CymaBay Therapeutics Stock Rocketed Nearly 8% Higher Today: https://g.foolcdn.com/editorial/images/751969/person-in-a-lab-looking-through-a-microscope.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNUs1YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--28a32f774ad605298683874feeac8c702b484e2e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/person-in-a-lab-looking-through-a-microscope.jpg?locale=us)
Why CymaBay Therapeutics Stock Rocketed Nearly 8% Higher Today
Hardly for the first time this year, biotech CymaBay Therapeutics (NASDAQ: CBAY) had a winning day on the market Monday. Following the news that its leading drug candidate had been granted an
![Why Revolution Medicines Stock Is Crashing Today: https://g.foolcdn.com/editorial/images/751899/scientist-with-head-down.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemU1YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9d0810e2d495d79046d32ad33223c9e6a291e4d4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/scientist-with-head-down.jpg?locale=us)
Why Revolution Medicines Stock Is Crashing Today
Shares of Revolution Medicines (NASDAQ: RVMD) were crashing 42.5% lower as of 11:13 a.m. ET on Monday. The steep decline came after the oncology company presented results on Sunday for RMC-6236 from
![3 Stocks Cathie Wood Is Buying That Should Be on Your List Too: https://g.foolcdn.com/editorial/images/751770/dna-genetic-sequencing-biotech-1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHU0YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--013ecba2a0144aae52ef19fd91cbd7715edb4198/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/dna-genetic-sequencing-biotech-1.jpg?locale=us)
3 Stocks Cathie Wood Is Buying That Should Be on Your List Too
Cathie Woods, through her various ARK funds, has been scooping up shares of Intellia Therapeutics (NASDAQ: NTLA), Block (NYSE: SQ), and Ginkgo Bioworks (NYSE: DNA) lately. All three stocks have
![AT&T Just Raised Its Free-Cash-Flow Guidance. Here's Why It Should Still Suspend Its Dividend.: https://g.foolcdn.com/editorial/images/751648/person-makes-phone-call-while-looking-at-information-on-a-tablet.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeUc0YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--67f613a7d7a2c4a30f3e6145e6bd67c3926b60a7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/person-makes-phone-call-while-looking-at-information-on-a-tablet.jpg?locale=us)
AT&T Just Raised Its Free-Cash-Flow Guidance. Here's Why It Should Still Suspend Its Dividend.
AT&T (NYSE: T) may finally have begun a long-awaited rebound. The stock surged 7% higher following its earnings announcement for the third quarter of 2023. A possible reason for the increase may
![3 Unstoppable Stocks to Buy Sooner Rather Than Later: https://g.foolcdn.com/editorial/images/751591/scientists-happy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEM0YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5efa253d45499b801832952a91db435d7605df73/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/scientists-happy.jpg?locale=us)
3 Unstoppable Stocks to Buy Sooner Rather Than Later
Some stocks have the "it" factor. They've got such tremendous growth prospects that investors want to add them to their portfolios without any hesitation.
Three Motley Fool investors think they've
![Pfizer Just Announced Layoffs. Should You Still Buy the Stock?: https://g.foolcdn.com/editorial/images/751579/investor-considers-papers-at-a-cafe.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK3kzYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--994a579e7f31c2a047a19fb55c77dfc83eb02c9c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/investor-considers-papers-at-a-cafe.jpg?locale=us)
Pfizer Just Announced Layoffs. Should You Still Buy the Stock?
On October 13, Pfizer (NYSE: PFE) served up a platter of bad news for investors. Aside from lowering its estimates for sales of its jab and its antiviral pill for COVID, the company reported that
![3 Safe Dividend Stocks to Beat Inflation: https://g.foolcdn.com/editorial/images/751608/chain-and-padlock-wrapped-around-stack-of-100-dollar-bills-cash-money-locked-up.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0czYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--532c20c5beb029f0de58c47dc2a4efd84ad2819c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/chain-and-padlock-wrapped-around-stack-of-100-dollar-bills-cash-money-locked-up.jpg?locale=us)
3 Safe Dividend Stocks to Beat Inflation
Like it or not, inflation remains higher than Americans have been accustomed to, and the impacts of last year's price surge have not gone away. As of September, inflation as measured by the Consumer
![If You Had Invested $10,000 in AT&T in 2013, This Is How Much You Would Have Today: https://g.foolcdn.com/editorial/images/749506/att-t-growth-stock-market-investment.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0czYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f1076e1635b427d647f12850e45d3cea7ee2176c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/att-t-growth-stock-market-investment.jpg?locale=us)
If You Had Invested $10,000 in AT&T in 2013, This Is How Much You Would Have Today
AT&T (NYSE: T) has a history dating back to the late 1800s. And over many periods of that long and storied history, it's been a fantastic stock to own.
However, over the last 10 years, AT&T stock
![Where Will AT&T Stock Be in 1 Year?: https://g.foolcdn.com/editorial/images/751680/att_retail_chicago.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOUszYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--500555c64283148694cbcaf16dbeebd64b0e3303/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/att_retail_chicago.jpg?locale=us)
Where Will AT&T Stock Be in 1 Year?
AT&T's (NYSE: T) stock rallied nearly 7% on Oct. 19 after the telecom giant posted its third-quarter earnings report. Its revenue rose 1% year over year to $30.35 billion and surpassed analysts'
![Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?: https://g.foolcdn.com/editorial/images/751646/jazz-pharma.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHkzYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--147009d804bdbcaa7b5f4f01f83d6f944288a8b7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/jazz-pharma.jpg?locale=us)
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
Pfizer (NYSE: PFE) and Roche (OTC: RHHBY) have disappointed investors this year. Pfizer's shares have dropped more than 39% this year, and it's trading near its 52-week low. Roche has seen its stock
![Is Pfizer a Bad News Buy Right Now?: https://g.foolcdn.com/editorial/images/751705/gettyimages-1203044156.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNyszYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--93f19c8a79ab5ac1e2697592a3c9c779df46454d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/gettyimages-1203044156.jpg?locale=us)
Is Pfizer a Bad News Buy Right Now?
Pfizer (NYSE: PFE) last year brought in record sales of more than $100 billion thanks to its dominance in the coronavirus prevention and treatment markets. The company sells the top vaccine
![Why AT&T Stock Was Gaining Today: https://g.foolcdn.com/editorial/images/751737/5g-cellular-communications-tower.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNG0zYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bef7b37fbfc6ca9e41f5dfd7ed66ecb27d9b4414/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/5g-cellular-communications-tower.jpg?locale=us)
Why AT&T Stock Was Gaining Today
Shares of AT&T (NYSE: T) were gaining for the second day in a row today as a flurry of positive analyst notes gave the stock another boost. As of 1:37 p.m. ET, the stock was up 1.5% after gaining as
![Why Knight-Swift Transportation Stock Popped Today: https://g.foolcdn.com/editorial/images/751717/truck-warehouse-loading-dock.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNE8zYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--907017b85d57aad3d83db2a78bcd3fdc6bcc506d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/truck-warehouse-loading-dock.jpg?locale=us)
Why Knight-Swift Transportation Stock Popped Today
Shares of Knight-Swift Transportation (NYSE: KNX) were moving higher today after the diversified transportation company topped analyst estimates in its third-quarter earnings report.
As of 11:27